Venture • Life Science

Bay City Capital Invests In OmegaTech

On October 1, 1999, venture capital firm Bay City Capital invested in life science company OmegaTech

Investment Context
  • This is Bay City Capital’s 9th transaction in the Life Science sector.
  • This is Bay City Capital’s 14th transaction in the United States.
  • This is Bay City Capital’s 1st transaction in Colorado.
Investment Fate
  • OmegaTech was sold to a publicly-traded strategic buyer in 2002 for 50M USD.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date October 1, 1999
Target OmegaTech
Sector Life Science
Investor(s) Bay City Capital
Deal Type Venture

Target Company

OmegaTech

Boulder, Colorado, United States
OmegaTech, Inc. is a developer and marketer of life science products from microalgae.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


Deal Context for Investor #
Overall 14 of 75
Sector: Life Science 9 of 54
Type: Venture 10 of 49
State: Colorado 1 of 3
Country: United States 14 of 72
Year: 1999 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-10-01 Senomyx

San Diego, California, United States

Senomyx is a producer of proprietary flavor and fragrance molecules for use in a wide range of consumer products. Senomyx’s integrated technology platform combines an enhanced understanding of the biology of taste and smell with many of the same technologies and advancements that pharmaceutical companies have recently begun using to more efficiently discover new medicines. Senomyx was founded in 1998 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
1999-11-18 Symyx Technologies

Santa Clara, California, United States

Symyx Technologies, Inc. is a develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications

Sell -